LASA SUPERGENERICS
Back to Cashflow Statement
|
LASA SUPERGENERICS Last 5 Year Cash Flow from Financing Activities History
[Standalone]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-1.93 Cr | ₹-4.16 Cr | ₹-0.04 Cr | ₹-36 Cr | ₹-9.85 Cr |
What is the latest Cash Flow from Financing Activities ratio of LASA SUPERGENERICS ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2024 | ₹-1.93 Cr |
| Mar2023 | ₹-4.16 Cr |
| Mar2022 | ₹-0.04 Cr |
| Mar2021 | ₹-36 Cr |
| Mar2020 | ₹-9.85 Cr |
How is Cash Flow from Financing Activities of LASA SUPERGENERICS Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2024 | ₹-1.93 Cr | Negative | |
| Mar2023 | ₹-4.16 Cr | Negative | |
| Mar2022 | ₹-0.04 Cr | Negative | |
| Mar2021 | ₹-36 Cr | Negative | |
| Mar2020 | ₹-9.85 Cr | - | |
Compare Cash Flow from Financing Activities of peers of LASA SUPERGENERICS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LASA SUPERGENERICS | ₹38.1 Cr | 10.5% | -4.4% | -58.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹396,370.0 Cr | -3.9% | -8.9% | -3.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹161,193.0 Cr | 3.8% | -4.7% | 11.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹141,438.0 Cr | 3.2% | -5.6% | 26.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,097.0 Cr | 3.3% | -6% | 11% | Stock Analytics | |
| CIPLA | ₹97,846.7 Cr | 0.8% | -9.1% | -13.1% | Stock Analytics | |
LASA SUPERGENERICS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LASA SUPERGENERICS | 10.5% |
-4.4% |
-58.7% |
| SENSEX | 3.7% |
-0.9% |
0.7% |
You may also like the below Video Courses